AmeriCann /

Our News

ACAN to Present at Rocky Mountain MicroCap Conference II

AmeriCann • April 24, 2018

Growing Political Support for Legalization Boosting Interest in Established Cannabis Companies


DENVER, CO / April 23, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, today announced that it will be presenting at the Rocky Mountain MicroCap Conference II in Denver, Colorado on Tuesday April 24th, 2018. For more information please visit:

The Conference is an invitation only investment forum designed for public microcap companies to present to a large gathering of investors.

Tim Keogh, CEO of AmeriCann, will be one of the featured speakers at the conference and will discuss the increasing momentum in Washington, DC toward the end of cannabis prohibition, states’ rights and other important industry trends.

He will also provide an update on the company’s highly anticipated Massachusetts Medical Cannabis Center (MMCC) large-scale campus style cannabis business park and research center the company is developing 47 miles from Boston.

The event organizers are expecting to host approximately 75 investors–mainly buy side portfolio and fund managers, analysts, family offices, brokers, and high net worth individual investors looking for growth opportunities in the microcap space. Investors with interest in attending should call Stephen Hart of Hayden IR at 917-658-7878.

AmeriCann, with offices in Denver and Boston, view the MMCC project as a showcase for the future of cannabis cultivation and processing.

Massachusetts is adding adult-use cannabis to it’s existing medical cannabis program on July 1, 2018, and industry experts believe it will become the epicenter for cannabis innovation and research for the entire northeast US with annual sales of over $1 billion by 2020.

The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the largest, most energy efficient and technologically advanced cannabis cultivation, processing, and research facilities in the nation. The company plans to replicate its technology and systems with expansion to other states.

About AmeriCann

AmeriCann (OTCQX: ACAN) is a publicly traded Agricultural Technology (Ag-Tech) company that is developing a new generation of sustainable, state-of-the-art medical cannabis cultivation and processing properties.


AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at:, or follow AmeriCann on Twitter@ACANinfo.


AmeriCann’s Massachusetts Venture Completes First Cannabis Harvest

New Massachusetts Facility is Supplying Much Needed Medical Cannabis March 31, 2020 / AmeriCann, Inc. (ACAN) a cannabis company that is developing state-of-the-art cultivation, processing…

AmeriCann • March 31, 2020

AmeriCann Comments on Constructive Protective Measures for Massachusetts Medical Patients

Medical cannabis businesses deemed an essential service and will continue to operate during the “Stay At Home” Advisory Denver, CO – AmeriCann, Inc. (ACAN) a…

AmeriCann • March 24, 2020